Merck’s eye drug Zioptan gains FDA approval
February 14, 2012Sales and Marketing Merck, Pfizer, Xalatan, Zioptan
The FDA has approved Merck’s eye solution Zioptan to treat a common eye condition. Zioptan (tafluprost ophthalmic solution) can now …
Premier Research appoints Sean Russell vice president, Marketing
February 14, 2012Research and Development, Sales and Marketing Premier Research, Quintiles, Sean Russell
Premier Research Group has announced the appointment of Sean Russell to the position of vice president, marketing.In this position, Russell …
NICE cannot recommend breast cancer drugs
February 14, 2012Sales and Marketing GSK, Herceptin, NHS, NICE, Roche, Tyverb
NICE is not recommending GlaxoSmithKline’s Tyverb or Roche’s Herceptin for use in certain breast cancer patients. The watchdog said in …
Robust sales for Shire
February 13, 2012Sales and Marketing Replagal, Shire, Vpriv, Vyvanse
A rise in the use of attention deficit and hyperactivity disorder drugs has helped push Shire’s turnover past $4 billion …
Lonza forges joint venture with South Africa for HIV drugs
February 13, 2012Manufacturing and Production HIV, Lonza, South Africa
Swiss contract manufacturer Lonza has signed a joint venture agreement with the government of South Africa that could significantly reduce …
Abbott plans €85m investment in Irish facility
February 13, 2012Manufacturing and Production Abbott. IDA, Ireland, Xinlay
Abbott Laboratories has said it will invest around €85 million in its manufacturing facility in Sligo, Ireland, more than doubling …
Excipient certification scheme launches
February 13, 2012Manufacturing and Production EXCiPACT, GDP, GMP, manufacturing
A consortium of industry associations has launched a certification scheme for pharmaceutical excipients to make it easier for drugmakers to …
Pharma manufacturing news in brief
February 13, 2012Manufacturing and Production Bosch, Lilly/Bend Research, Neuland, OctoPlus Ferring and CHEMO Particle Sciences
Neuland posts revenue gains, Bosch buys Eisi machinery, plus deals for Lilly/Bend Research, OctoPlus/Ferring and CHEMO/Particle Sciences.
Carlyle Ware joins the Fishawack Group
February 13, 2012Business Services, Medical Communications, Sales and Marketing Fishawack Group, PR, fishawack
Med comms specialist the Fishawack Group has appointed Carlyle Ware as its group commercial director. Ware has over 13 years’ …
NHS productivity not declining: Lancet study
February 13, 2012Sales and Marketing Lancet, Lansley, NHS reform
A new study by the Lancet has shown that productivity in the NHS has improved over the past ten years. …
SHL takes part in PharmTech.com’s “Pointed Debate: Expert Views on Injectables”
February 13, 2012Manufacturing and Production auto injector, auto-injector, pen injector, shl group
SHL recently had the opportunity to participate along with various other experts in the industry in a questionnaire held by …
Quintiles launches new Asian market service
February 13, 2012Research and Development Asia, Quintiles, emerging markets
Contract research and consulting firm Quintiles has launched two new services to help pharma improve their chances of developing and …
FDA grants Roche’s pertuzumab priority review
February 10, 2012Sales and Marketing Herceptin, Roche, pertuzumab
The FDA has accepted Roche’s potential breast cancer treatment pertuzumab for appraisal and granted the drug priority review. The proposed …
Lundbeck appoints European leaders
February 10, 2012Medical Communications, Sales and Marketing Cipralex, Lundbeck
Lundbeck has appointed two new regional vice presidents for European markets, in time for new drug launches.João Rocha is to …
PR agencies warn of ‘race to the bottom’
February 10, 2012Medical Communications HCA, PR
A new survey of PR agencies working in healthcare has highlighted concerns about cost-cutting which they say could lower standards …
Value destruction: pharma has only itself to blame
February 10, 2012R&D productivity
Pharma has only itself to blame for destroying value from its R&D pipeline, according to Andrew Baum, managing director of …
MPs support health and social care integration
February 10, 2012Sales and Marketing NHS, social care
The integration of care services will help improve outcomes for older people and those with disabilities and long-term conditions, according …
Oxford BioMedica makes management change
February 10, 2012Research and Development, Sales and Marketing Oxford BioMedica
Gene-based biopharmaceutical firm Oxford BioMedica has announced that Andrew Wood, chief financial officer, has stepped down from the board of Oxford …
Chiltern welcomes Gastroenterology, Oncology and Pediatric Therapeutic experts to their team
February 9, 2012Research and Development
Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Drs. Marcelo Piccirillo and Carlo Lanza have joined …
Doctors, medical education and pharma – the way ahead
February 9, 2012Medical Communications ABPI, ASME, CME, Continuing medical education, GMC, MEP
InPharm CME event Roy Pounder, Andrew Powrie-Smith, Richard Marchant, Roy Lilley, Kieran Walsh and Chuka Nwokolo are all speakers at …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
AI: an early warning system for patient safety
Highlighting the value of lab research for healthcare innovation
